Posted on
October 25, 2022

Meet the a2 Collective at GSA 2022

Schedule a one-on-one conversation with leadership from your AITC of choice or the a2 Collective Coordinating Center


The a2 Collective is pleased to share that Principal Investigators and Pilot Core leaders from the AITCs and leadership from the a2 Collective Coordinating Center will be attending the GSA 2022 Annual Scientific Meeting in Indianapolis, IN, next week and are excited to meet with those interested in learning more about the a2 Collective! Conversation slots are available to meet with an a2 Collective representative during GSA. Please click below to schedule a 15-minute one-on-one conversation:

Schedule a one-on-one meeting with JH AITC at GSA 2022

Schedule a one-on-one meeting with MassAITC at GSA 2022

Schedule a one-on-one meeting with PennAITech at GSA 2022

Schedule a one-on-one meeting with the a2 Collective Coordinating Center at GSA 2022

We encourage you to sign up in advance to secure a meeting with your preferred point of contact or stop by booth #212 to learn more about our exciting work in this emerging field!

The a2 Collective represents the Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program, which is dedicated to helping Americans live longer, healthier lives through the application of artificial intelligence (AI) and emerging technologies. The AITC program is funded by the National Institute on Aging, part of the National Institutes of Health, and comprises three AITCs centered at Johns Hopkins University (JH AITC), the University of Massachusetts Amherst (MassAITC), and the University of Pennsylvania (PennAITech) and the a2 Collective Coordinating Center.

Our team is working on multiple fronts, including commissioning original AgeTech research and publications; organizing learning webinars, workshops, and symposiums; and hosting the a2 Pilot Awards, an annual national competition with $40M earmarked to fund promising AI technology pilot projects that seek to improve care and health outcomes for older Americans, including persons with Alzheimer’s disease and related dementias (AD/ADRD). We look forward to discussing these efforts and more with GSA attendees Nov. 2-5.